Specialty Diagnostics
at Every Stage of
Cancer Care

We help you navigate the complex treatment landscape, connecting insights from patients, trials, health systems and managed care partners to power decisions that improve patient outcomes.

Delivering Critical Insights at Every
Step of Patient Care

Our testing gives you both flexibility and reliability. You can reduce turnaround time by working with your local Labcorp lab, integrating our data directly into your electronic health records, and trusting the accuracy and relevance that comes with diagnostics that are continually refined based on expansive data from our industry-leading central labs and drug development services.

View Test Menu

Screening
Helping your patients stay ahead of cancer with tests that support risk assessment and screening, like BRCAssure® and VistaSeq®—multi-gene tests that detect inherited mutations in genes associated with an increased risk of developing hereditary cancers.
Diagnosis and Prognosis
We offer the full range of diagnostic tests through tissue biopsy, cytology, genomic and molecular tests, and other blood tests and digital pathology, while our predictive tests help determine therapy selection and management via NGS, IHC and liquid biopsies.
Key NGS tests include IntelliGEN^® Myeloid, OmniSeq INSIGHT^® and Plasma Focus™.
Treatment Planning
Many of our precision medicine tests include therapeutic implications, FDA-approved or guideline-supported treatment recommendations, possible resistance information and clinical trial recommendations based on known aspects of the patient's eligibility.
Key NGS tests include IntelliGEN^® Myeloid, OmniSeq INSIGHT^® and Plasma Focus™.
Monitoring
We know your testing needs go beyond screening and diagnosis, so we offer testing solutions to help monitor patients during the full course of their treatment. Whether testing for risk of recurrence to identify additional maintenance therapy, or to follow a patient post-trial using our decentralized trial and remote monitoring capabilities, you can rely on us to support your treatment efforts to remission and beyond.
Key tests include IntelliGEN^® Myeloid, PML/RARA t(15;17), BCR/ABL t(9;21), All MRD and CLL MRD by flow cytometry.

ScreeningScreening
02Diagnosis and Prognosis
03Treatment Planning
04Monitoring

Screening

Helping your patients stay ahead of cancer with tests that support risk assessment and screening, like BRCAssure® and VistaSeq®—multi-gene tests that detect inherited mutations in genes associated with an increased risk of developing hereditary cancers.

Diagnosis and Prognosis

We offer the full range of diagnostic tests through tissue biopsy, cytology, genomic and molecular tests, and other blood tests and digital pathology, while our predictive tests help determine therapy selection and management via NGS, IHC and liquid biopsies.

Key NGS tests include IntelliGEN^® Myeloid, OmniSeq INSIGHT^® and Plasma Focus™.

Treatment Planning

Many of our precision medicine tests include therapeutic implications, FDA-approved or guideline-supported treatment recommendations, possible resistance information and clinical trial recommendations based on known aspects of the patient's eligibility.

Key NGS tests include IntelliGEN^® Myeloid, OmniSeq INSIGHT^® and Plasma Focus™.

Monitoring

We know your testing needs go beyond screening and diagnosis, so we offer testing solutions to help monitor patients during the full course of their treatment. Whether testing for risk of recurrence to identify additional maintenance therapy, or to follow a patient post-trial using our decentralized trial and remote monitoring capabilities, you can rely on us to support your treatment efforts to remission and beyond.

Key tests include IntelliGEN^® Myeloid, PML/RARA t(15;17), BCR/ABL t(9;21), All MRD and CLL MRD by flow cytometry.

Labcorp Oncology Capabilities
Across the Continuum of Care

Comprehensive Genomic Profiling

Labcorp is determined to help you identify the ideal treatment path using the right
test so you can deliver the best possible outcomes based on the most relevant data.

OmniSeq INSIGHT®

The only all-in-one test that includes comprehensive genomics and immune profiling from a single tissue sample to identify all FDA-approved therapeutics, confirm immunotherapy eligibility for a patient and identify appropriate nearby clinical trials.

Learn More

IntelliGEN® Myeloid

An NGS-based genomic assay that evaluates 50 of the most clinically relevant genes mutated in myeloid malignancies to provide diagnostic, prognostic and predictive insights.

Learn More

Labcorp® Plasma Focus™

A guideline-driven liquid biopsy test that targets 33 clinically actionable or relevant genes for advanced solid tumors

Learn More

Informing and Supporting Your Treatment Decisions

We support you with insights about which diagnostics to order—and why—and what
treatment path to consider, including clinical trials. You can rely on our team of oncology
experts to help you through it all.

Bringing You the Power
of Precision Medicine

Our diagnostic tests for biomarkers, like PD-L1 (for treatment with KEYTRUDA® [pembrolizumab]) and EGFR (for treatments like osimertinib, afatinib and erlotinib), help determine appropriate precision medicine with speed and accuracy. Learn about our expertise and the experience of the specialists who shape our efforts.

Learn More

Facilitating Clinical Trial Participation as a Treatment Option

Empowering Patients to Participate
in Clinical Trials

We’re reducing barriers to clinical trials and making participation easier for you and your patients through a comprehensive and easy to navigate tool that directly connects the right patients to the right trials that can make a difference in their condition.

Learn More